Concepedia

Author

Wayne Rackoff

Johnson & Johnson (United States)

Also Known As

W R Rackoff, W Rackoff, W. Rackoff, WAYNE R. RACKOFF, Wayne R. Rackoff, Wayne Rackoff

46

Publications

3.9K

Citations

20

H-Index

37

Concepts

All Affiliations

Johnson & Johnson (United States)Riley Hospital for ChildrenOregon Health & Science UniversityMassachusetts General HospitalUCSF Helen Diller Family Comprehensive Cancer Center
WR

About

Wayne Rackoff is an author at Johnson & Johnson (United States) specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

746

2

Health Sciences

2

2

20

3

Cell Biology

1

1

32

4

Emergency Medicine

1

1

48

5

Gastroenterology

1

1

48

Wayne Rackoff

×

28

Publications

3.9K

Citations

20

H-Index

YearCitations

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

Matthew R. Smith, Fred Saad, Simon Chowdhury,

New England Journal of Medicine

2018

1.3K

Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression

Robert Z. Orlowski, Arnon Nagler, Pieter Sonneveld,

Journal of Clinical Oncology

2007

644

Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer

Alan N. Gordon, Margaret Tonda, Steven Sun,

Gynecologic Oncology

2004

430

Predicting the risk of bacteremia in childen with fever and neutropenia.

Wayne Rackoff, R Gonin, Caroline O Robinson,

Journal of Clinical Oncology

1996

227

Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies

Jörge E. Cortes, Maher Albitar, Deborah A. Thomas,

Blood

2003

209

Pegylated Liposomal Doxorubicin Plus Docetaxel Significantly Improves Time to Progression Without Additive Cardiotoxicity Compared With Docetaxel Monotherapy in Patients With Advanced Breast Cancer Previously Treated With Neoadjuvant-Adjuvant Anthracycline Therapy: Results From a Randomized Phase III Study

Joseph A. Sparano, Semiglazov Vf, Sergei Tjulandin,

Journal of Clinical Oncology

2009

116

A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children

Wayne Rackoff, Marjorie Weiman, Diane Jakobowski,

The Journal of Pediatrics

1995

105

Double-Blind, Placebo-Controlled Study of Quality of Life, Hematologic End Points, and Safety of Weekly Epoetin Alfa in Children With Cancer Receiving Myelosuppressive Chemotherapy

Bassem I. Razzouk, Jeffrey D. Hord, Marilyn Hockenberry,

Journal of Clinical Oncology

2006

99

Neurologic events after partial exchange transfusion for priapism in sickle cell disease

Wayne Rackoff, Kwaku Ohene‐Frempong, Stacy Month,

The Journal of Pediatrics

1992

88

A Randomized, Double-Blind Study of Pegylated Liposomal Doxorubicin for the Treatment of AIDS-Related Kaposi's Sarcoma

Timothy P. Cooley, David H. Henry, Margaret Tonda,

The Oncologist

2007

82

Page 1